• Biogen to Start Re-dosing Aducanumab in Alzheimer’s Patients From Halted Trials
  • Number of Dementia Cases Likely to Double by 2050 as Europe Ages, Report Says
  • Cortexyme Advances COR388 Clinical Development Program in Alzheimer’s Disease After FDA Meeting
  • Small Gestures on Valentine’s Day Can Mean a Lot to Caregivers
  • Scientists Use CRISPR-Cas9 as ‘DNA Scissors’ to Cut Out Alzheimer’s Gene in Mice, Study Shows
  • Chaperone Works to Lessen Alzheimer’s Symptoms and Toxic Protein Buildup, Mouse Study Says
  • Memory Health Awarded UK Patent as Alzheimer’s Treatment
  • NIH Awards $4.8M Grant to Project Investigating the Role of ApoE4 Gene Variant in Alzheimer’s
  • The Link Between Alzheimer’s Research and Black History
  • Alzheimer’s Patients, Clinicians, Industry Representatives Urge Better Access to PET Scans
  • Phase 1b Trial Begins to Test Alector’s Immune-system Targeting Antibody AL003 in Alzheimer’s Patients
  • Inflammatory Conditions Linked to Higher Risk of Alzheimer’s
Latest Posts
    The User does not have any posts